An additional piece in the Israeli celiac disease puzzle

Israel Medical Association Journal

Volumn 12, Issue 5, 2010, Pages 305-306

  Lerner, Aaron ^a,b  

^a CARMEL MEDICAL CENTER   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Adult; Celiac disease; Israel; Prevalence

Indexed keywords

ENDOMYSIUM ANTIBODY; GLIADIN ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY; GUANINE NUCLEOTIDE BINDING PROTEIN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2;

ANTIBODY DETECTION; BLOOD ANALYSIS; BLOOD DONOR; CELIAC DISEASE; EDITORIAL; ENZYME LINKED IMMUNOSORBENT ASSAY; GLUTEN FREE DIET; HUMAN; INTESTINE BIOPSY; ISRAEL; MASS SCREENING; PATIENT COMPLIANCE; PREVALENCE; SAMPLING; SEROLOGY; SOLDIER; SYSTEMATIC ERROR; BLOOD; JEW; PROCEDURES; STATISTICS AND NUMERICAL DATA;

CELIAC DISEASE; GTP-BINDING PROTEINS; HUMANS; ISRAEL; JEWS; MASS SCREENING; PREVALENCE; TRANSGLUTAMINASES;

EID: 77953515184     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (22)

1. Israeli E, Hershcovici T, Grotto I, Rouach Z, Branski D, Goldin E. Prevalence of celiac disease in an adult Jewish population in Israel. IMAJ Isr Med Assoc J 2010; 12: 00-00.
2. Yagil Y, Goldenberg I, Arnon R, Ezra V, Ashkenazi I. Serologic testing for celiac disease in young adults - a cost-effect analysis. Dig Dis Sci 2005; 50: 796-805.
3. Shamaly H, Mahameed A, Sharony A, Shamir R. Infertility and celiac disease: do we need more than one serological marker? Acta Obstet Gynecol Scand 2004; 83: 1184-8.
4. Shamir R, Lerner A, Shinar E, et al. The use of a single serological marker underestimates the prevalence of celiac disease in Israel: a study of blood donors. Am J Gastroenterol 2002; 97: 38-43.
5. Lerner A, Lebenthal E. The controversy of antigluten antibody (AGA) as a diagnostic tool in celiac disease [Editorial]. J Pediatr Gastroenterol Nutr 1991; 12: 407-09.
6. Shamir R, Eliakim R, Lahat N, Sobel E, Lerner A. ELISA assay of anti-endomysial antibodies in the diagnosis of celiac disease: comparison with immunofluorescence assay of anti-endomysial antibodies and tissue transglutaminase antibodies. IMAJ Isr Med Assoc J 2002; 4: 594-6.
7. Reif S, Lerner A. Tissue transglutaminase - the key player in celiac disease: a review. Autoimmun Rev 2004; 3: 40-5.
8. Dickey W, Hughes DF, Mcmillan SA. Reliance on serum endomysial antibody testing underestimates the true prevalence of celiac disease by one fifth. Scand J Gastroenterol 2000; 35: 181-3.
9. Tesei N, Sugai E, Vazquez H, et al. Antibodies to human recombinant tissue transglutaminase may detect coeliac disease patients undiagnosed by endomysial antibodies. Aliment Pharmacol Ther 2003; 17: 1415-23.
10. Weiss B, Bujanover Y, Avidan B, Fradkin A, Weintraub I, Shainberg B. Positive tissue transglutaminase antibodies with negative endomysial antibodies: low rate of celiac disease. IMAJ Isr Med Assoc J 2004; 6: 9-12.
11. Prause C, Richter T, Koletzko S, et al. New developments in serodiagnosis of childhood celiac disease: assay of antibodies against deaminated gliadins. Ann NY Acad Sci 2009; 1173: 28-35.
12. Bansal AK, Lindemann MJ, Ramsperger V, Kumar V. Celiac G+ antibody assay for the detection of autoantibodies in celiac disease. Ann NY Acad Sci 2009; 1173: 36-40.
13. Matthias T, Pfeiffer S, Selmi C, Eric Gershwin M. Diagnostic challenges in celiac disease and the role of the tissue transglutaminase-neo-epitope. Clin Rev Allergy Immunol 2009; 38: 298-301.
14. Rashtak S, Ettore MW, Homburger HA, Murray JA. Combination testing for antibodies in the diagnosis of coeliac disease: comparison of multiplex immunoassay and ELISA methods. Aliment Pharmacol Ther 2008; 28: 805-13.
15. Dorn SD, Matchar DB. Cost-effectiveness analysis of strategies for diagnosing celiac disease. Dig Dis Sci 2008; 53: 680-8.
16. Fasano A. Should we screen for celiac disease? Yes. BMJ 2009; 339: b3592.
17. Evans K, McAllister R, Sanders DS. Should we screen for celiac disease? No. BMJ 2009; 339: b3674.
18. Ravikumara M, Nootigattu VK, Sandhu BK. Ninety percent of celiac disease is being missed. J Pediatr Gastroenterol Nutr 2007; 45: 497-9.
19. Evans KE, Malloy AR, Gorard DA. Changing patterns of coeliac disease requests. Aliment Pharmacol Ther 2009; 29: 1137-42.
20. Rubio-Tapia A, Kyle RA, Kaplan EL, et al. Increased prevalence and mortality in undiagnosed celiac disease. Gastroenterolgy 2009; 137: 88-93.
21. Shamir R, Yehezkely-Schildkraut V, Hartman C, Eliakim R. Population screening for celiac disease: follow up of patients identified by positive serology. J Gastroenterol Hepatol 2006; 22: 532-5.
22. Lerner A. New therapeutic strategies for celiac disease. Autoimmune Rev 2009; 9: 144-7.